×
About 383 results

ALLMedicine™ Pediatric Atopic Dermatitis Center

Research & Reviews  111 results

Predictive biomarker modeling of pediatric atopic dermatitis severity based on longitud...
https://doi.org/10.1093/cei/uxab009
Clinical and Experimental Immunology; Engle SM, Chang CY et. al.

May 14th, 2022 - The pathogenesis of atopic dermatitis (AD) results from complex interactions between environmental factors, barrier defects, and immune dysregulation resulting in systemic inflammation. Therefore, we sought to characterize circulating inflammatory...

Evolving Landscape of Systemic Therapy for Pediatric Atopic Dermatitis.
https://doi.org/10.1016/j.det.2021.12.002
Dermatologic Clinics; Lockhart MK, Siegfried EC

Apr 4th, 2022 - Atopic dermatitis (AD) is the most common chronic inflammatory skin disease in children. Standard-of-care treatment has been topical therapy. Oral corticosteroids are also commonly used to treat intermittent flares, despite guidelines that recomme...

The Skin and Nose Microbiome and Its Association with Filaggrin Gene Mutations in Pedia...
https://doi.org/10.1159/000520978
Dermatology (Basel, Switzerland); van Mierlo MMF, Pardo LM et. al.

Jan 19th, 2022 - Interactions between the skin barrier, immune system, and microbiome underlie the development of atopic dermatitis (AD). To investigate the skin and nasal microbiome in relation to filaggrin gene (FLG) mutations. A cross-sectional study including ...

Predictive biomarker modeling of pediatric atopic dermatitis severity based on longitud...
https://doi.org/10.1093/cei/uxab009
Clinical and Experimental Immunology; Engle SM, Chang CY et. al.

Jan 13th, 2022 - The pathogenesis of atopic dermatitis (AD) results from complex interactions between environmental factors, barrier defects, and immune dysregulation resulting in systemic inflammation. Therefore, we sought to characterize circulating inflammatory...

see more →

Clinicaltrials.gov  6 results

Probiotic Lactobacillus Rhamnosus GG for Pediatric Atopic Dermatitis
https://clinicaltrials.gov/ct2/show/NCT03863418

Mar 6th, 2019 - Atopic dermatitis (AD) is a multifactorial, chronic inflammatory skin disorder that results in areas of dry, itchy skin. AD affects up to 20% of children in Western societies and represents a prevalent, burdensome, and psychologically important pe...

Pediatric Atopic Dermatitis (AD) Internet Survey
https://clinicaltrials.gov/ct2/show/NCT01385527

Jul 6th, 2018 - The purpose of this study is to evaluate whether participation in an Internet-based intervention helps improve atopic dermatitis treatment outcomes.

Behavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema Patients
https://clinicaltrials.gov/ct2/show/NCT02713035

Feb 19th, 2018 - Background Psychological interventions for atopic dermatitis (AD) in children are not well-studied, despite the potential benefits, which may include: decreased need for medications and improved long-term control of both dermatologic symptoms as w...

Establishing the Collaborative Care Model of Traditional Chinese Medicine and Western Medicine-Pediatric Atopic Dermatitis
https://clinicaltrials.gov/ct2/show/NCT03375970

Dec 18th, 2017 - In Taiwan, there are many patients suffer from pediatric atopic dermatitis. Because of the clinical characteristic of repetitive and scratchy, which will affect the patients' quality of life and lead to the medical heavy budget. TCM may play an im...

Oregano Ointment vs. Standard Treatment for Pediatric Atopic Dermatitis
https://clinicaltrials.gov/ct2/show/NCT02289989

May 10th, 2017 - A single-center, investigator initiated, randomized controlled, double-blind trial will be conducted to determine the effects of an oregano extract in aqueous solution versus 1% hydrocortisone in the treatment of acute-subacute pediatric atopic de...

see more →

News  36 results

Dupilumab is effective for pediatric atopic dermatitis across different anatomical regions
http://www.mdedge.com/dermatology/article/246290/atopic-dermatitis/dupilumab-effective-pediatric-atopic-dermatitis-across

Sep 18th, 2021 - Key clinical point: Dupilumab improved signs of atopic dermatitis (AD) rapidly and consistently across all anatomical regions in pediatric patients. Major finding: In children, dupilumab improved Eczema Area and Severity Index (EASI) score as earl.

Serum biomarker-based patient clusters identify heterogeneity in pediatric atopic dermatitis
https://www.mdedge.com/dermatology/article/243635/atopic-dermatitis/serum-biomarker-based-patient-clusters-identify

Jul 29th, 2021 - Key clinical point: Analysis of serum biomarker profiles in pediatric patients with atopic dermatitis (AD) indicates the existence of unique endotypes that could predict patients at risk of persistent disease and guide personalized, endotype-drive.

Fast Five Quiz: Pediatric Atopic Dermatitis
https://reference.medscape.com/viewarticle/951789

Jun 7th, 2021 - Atopic dermatitis (AD) is the most common inflammatory skin disease among children. This chronic disorder is immunologic in nature and is characterized by pruritic lesions. The condition arises by age 5 years in most pediatric patients and often s...

Fast Five Quiz: Severe Pediatric Atopic Dermatitis
https://reference.medscape.com/viewarticle/944893

Mar 15th, 2021 - Atopic dermatitis, often called atopic eczema, is a chronic, pruritic inflammatory skin condition that typically affects the face (cheeks), neck, arms, and legs but usually spares the groin and axillary regions. It is common worldwide, affecting u...

Are pediatric and adult dermatitis the same disease?
https://www.mdedge.com/dermatology/article/235185/atopic-dermatitis/are-pediatric-and-adult-dermatitis-same-disease
Doug Brunk

Jan 28th, 2021 - Are pediatric atopic dermatitis and atopic dermatitis the same disease? Dr. Jonathan I.

see more →